Related Experiment Video
Updated: Jun 8, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function
Dagmar-Christiane Fischer1, Claudia Jensen, Anja Rahn
1Department of Pediatrics, University Children's Hospital Rostock, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany. dagmar-christiane.fischer@med.uni-rostock.de
Ibandronate, a bisphosphonate, was found to impede tibial growth and bone mineralization in young rats. This effect was observed in both healthy rats and those with chronic renal failure (CRF).
Area of Science:
- Pharmacology
- Bone Biology
- Nephrology
Background:
- Bisphosphonates are known to reduce bone turnover.
- Their impact on endochondral bone formation, particularly in chronic renal failure (CRF), remains under-investigated.
- Ectopic calcification in experimental uremia can be attenuated by bisphosphonates.
Purpose of the Study:
- To investigate the effects of ibandronate on endochondral bone formation in rats with normal and reduced renal function.
- To determine if ibandronate impacts tibial growth and mineralization in the context of chronic renal failure.
Main Methods:
- Male Sprague-Dawley rats were administered weekly subcutaneous injections of vehicle or ibandronate (1.25 μg/kg) for 10 weeks.
- Rats were either sham-operated or 5/6 nephrectomized to induce chronic renal failure (CRF).
- Tibiae were analyzed after in vivo double labeling with tetracycline and demeclocycline.
Main Results:
- Ibandronate reduced body length gain and tibial growth rate in sham-operated rats but not in CRF rats.
- The proliferative zone of the epiphyseal growth plate was reduced by ibandronate in control rats and tended to be reduced in CRF rats.
- Mineral apposition rates were significantly reduced in ibandronate-treated rats, with a similar trend observed in CRF rats.
Conclusions:
- Ibandronate interferes with tibial growth and bone mineralization in young rats.
- The drug's impact on growth and mineralization may differ between rats with normal and reduced renal function.
- Further research is needed to fully elucidate the effects of bisphosphonates on bone formation in CRF.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling
Antihypertensive Drugs: Direct Renin Inhibitors
